{
    "nct_id": "NCT05528263",
    "official_title": "Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture, A Randomized Controlled Trial (PACT Trial)",
    "inclusion_criteria": "* History of histologically proven stage I-III breast cancer, without evidence of distant metastasis\n* Scheduled to receive adjuvant or neoadjuvant taxane-based chemotherapy (with or without HER-2 directed therapy or with or without immunotherapy). Patient must enroll before the second infusion of a taxane.\n* Age â‰¥ 18 years\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n* Signed informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous receipt of CIPN-inducing chemotherapy agents (1 prior dose of a taxane is allowed).\n* Unstable cardiac disease or myocardial infarction within 6 months prior to study entry\n* Wearing a pacemaker or implantable cardioverter-defibrillator\n* Uncontrolled seizure disorder\n* History of pre-existing peripheral neuropathy\n* Use of acupuncture within the 3 months prior to study enrollment\n* Self-report of any CIPN symptoms via staff-administered PRO-CTCAE CIPN, defined as either:\n\n  * Report of \"mild\", \"moderate\", \"severe\", \"very severe\" on the Severity Item on PRO-CTCAE CIPN assessment\n  * Report of \"a little bit\", \"somewhat\", \"quite a bit\", \"very much\" on the Interfere Item on PRO-CTCAE CIPN assessment",
    "miscellaneous_criteria": ""
}